Plus Therapeutics Inc [NASDAQ: PSTV] closed the trading session at $0.38 on 2025-07-21. The day’s price range saw the stock hit a low of $0.3611, while the highest price level was $0.41.
The stocks have a year to date performance of -78.61 percent and weekly performance of 14.18 percent. The stock has been moved at -67.73 percent over the last six months. The stock has performed 89.63 percent around the most recent 30 days and changed -41.69 percent over the most recent 3-months.
If compared to the average trading volume of 26.69M shares, PSTV reached to a volume of 12976280 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Plus Therapeutics Inc [PSTV]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for PSTV shares is $10.83 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PSTV stock is a recommendation set at 1.67. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
D. Boral Capital have made an estimate for Plus Therapeutics Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on March 17, 2025. While these analysts kept the previous recommendation, Ladenburg Thalmann raised their target price to Buy. The new note on the price target was released on January 25, 2021, representing the official price target for Plus Therapeutics Inc stock. Previously, the target price had yet another raise to $6, while Maxim Group analysts kept a Buy rating on PSTV stock.
PSTV stock trade performance evaluation
Plus Therapeutics Inc [PSTV] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 14.18. With this latest performance, PSTV shares gained by 89.63% in over the last four-week period, additionally sinking by -67.73% over the last 6 months – not to mention a drop of -66.61% in the past year of trading.
Plus Therapeutics Inc [PSTV]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Plus Therapeutics Inc [PSTV] shares currently have an operating margin of -286.82% and a Gross Margin at 83.73%. Plus Therapeutics Inc’s Net Margin is presently recorded at -520.90%.
Plus Therapeutics Inc (PSTV) Capital Structure & Debt Analysis
Plus Therapeutics Inc (PSTV) Efficiency & Liquidity Metrics
Plus Therapeutics Inc (PSTV) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Plus Therapeutics Inc. (PSTV) effectively leverages its workforce, generating an average of -$1291428.57 per employee. The company’s liquidity position is robust, with a Current Ratio of 0.99% and a Quick Ratio of 0.99%, indicating strong ability to cover short-term liabilities.
Earnings per share (EPS) analysis for Plus Therapeutics Inc [PSTV] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for PSTV. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Plus Therapeutics Inc go to 49.58%.
Plus Therapeutics Inc [PSTV]: Institutional Ownership
There are presently around $2.50%, or 2.55%% of PSTV stock, in the hands of institutional investors. The top three institutional holders of PSTV stocks are: AIGH CAPITAL MANAGEMENT LLC with ownership of 0.57 million shares, which is approximately 8.7478%. GEODE CAPITAL MANAGEMENT, LLC, holding 46648.0 shares of the stock with an approximate value of $$68572.0 in PSTV stocks shares; and GEODE CAPITAL MANAGEMENT, LLC, currently with $$47835.0 in PSTV stock with ownership which is approximately 0.5006%.
